Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine.

Hu, Yun; Smith, Daniel; Frazier, Evan; Zhao, Zongmin; Zhang, Chenming

Hu, Yun; Smith, Daniel; Frazier, Evan; Zhao, Zongmin; Zhang, Chenming.

Afiliação

Hu Y; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
Smith D; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
Frazier E; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
Zhao Z; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
Zhang C; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.

Mol Pharm ; 18(3): 1293-1304, 2021 03 01.

Article em En | MEDLINE | ID: mdl-33497574

Assuntos

Nanopartículas/química; Nicotina/imunologia; Receptor Toll-Like 9/agonistas; Vacinas/imunologia; Adjuvantes Imunológicos/farmacologia; Adjuvantes Farmacêuticos/farmacologia; Animais; Feminino; Imunização/métodos; Camundongos; Camundongos Endogâmicos BALB C; Oligodesoxirribonucleotídeos/imunologia; Receptor Toll-Like 9/imunologia; Vacinação/métodos

Palavras-chave

CpG ODN; adjuvant; hybrid nanoparticle; nicotine vaccine; smoking cessation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Vacinas / Receptor Toll-Like 9 / Nanopartículas / Nicotina Limite: Animals Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google